# Aktis Oncology, Inc.: Form 8-K, filed May 11, 2026

- Company: [Aktis Oncology, Inc.](/companies/akts.md) (CIK 2035832)
- Form: 8-K
- Filed: 2026-05-11
- Accepted by EDGAR: May 11, 2026, 16:04 ET
- Period: 2026-05-11
- Accession: 0001193125-26-216716
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2035832/000119312526216716/ck0002035832-20260511.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2035832/000119312526216716/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2035832/000119312526216716/ck0002035832-20260511.htm

Filed May 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-216716. Last ingested by Listed: Nov 12, 2026, 18:12 ET. No prices; not investment advice.
